Lazo-Langner A, Louzada M, Garg A, et al. Assessing the risk-benefit of anticoagulants in elkderly patients with cancer-associated venous thromboembolism; a population based study. EHA 2017, abstract S441.
Tislelizumab plus zanubrutinib bij Richter-transformatie: een fase II-studie
mrt 2024 | Leukemie, Lymfoom